AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24373998
Drug: PT302 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT302 (4 mg)
Trial: 24373998
Drug: PT302 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT302 (0.5 mg, 1 mg, 2 mg, 4 mg)
Trial: 18839781
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral therapy (HAART; zidovudine [ZDV], lamivudine, and nevirapine [NVP])
Trial: 18839781
Drug: Short-course ZDV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course ZDV plus single-dose NVP (ZDV/NVP)
Trial: 11986476
Drug: Short-course antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course antibiotic therapy (</=3 days)
Trial: 11986476
Drug: Short-course antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course antibiotic therapy (single-dose or 1-day)
Trial: 11986476
Drug: Short-course antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course antibiotic therapy (3-day)
Trial: 10524723
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group received additional information about stop signals (three oral, one written) before injections.
Trial: 7761218
Drug: Chemotherapy at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy at home
Trial: 7761218
Drug: Chemotherapy in
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy in the hospital
Trial: 2148014
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 20 mg TID
Trial: 2148014
Drug: Domperidone (DP)
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (DP) 20 mg TID
Trial: 2148014
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of MPA and DP
Trial: 6985836
Drug: Levamisole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (150 mg daily x 3)
Trial: 25491704
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy only
Trial: 25491704
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy combined with motivational interviewing and a peer support group
Trial: 9737478
Drug: Enoxaparin, ticlopidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, ticlopidine, and aspirin
Trial: 9737478
Drug: Warfarin anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin anticoagulant treatment
Trial: 22794665
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (Control)
Trial: 21718265
Drug: Twice-weekly balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly balance and tone exercises (control)
Trial: 26363985
Drug: Locoregional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locoregional treatment
Trial: 26363985
Drug: No locoregional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No locoregional treatment
Trial: 21156001
Drug: Low-calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium diet + probiotic (2 g/kg diet)
Trial: 21156001
Drug: Low-calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium diet + prebiotic (2 g/kg diet)
Trial: 21156001
Drug: Low-calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium diet + synbiotic (mix of probiotic and prebiotic, each 2 g/kg diet)
Trial: 21156001
Drug: Low-calcium diet
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium diet + organic acid (1.5 g/kg diet)
Trial: 19922882
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg/d)
Trial: 19922882
Drug: Enalapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5 mg/d)
Trial: 17097814
Drug: exercise+nicotine patch
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: exercise+nicotine patch
Trial: 17097814
Drug: exercise+no nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: exercise+no nicotine patch
Trial: 17097814
Drug: cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cognitive behavior therapy (CBT)+nicotine patch
Trial: 17097814
Drug: CBT+no nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBT+no nicotine patch
Trial: 8363392
Drug: Enoxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxacin (200 mg/12 h for 3 days)
Trial: 8363392
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil (125 mg/12 h for 7 days)
Trial: 3534857
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg every 8 hours for 1 month
Trial: 3534857
Drug: Digoxin 0.25
RxNorm normalized name: digoxin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.25 mg once a day for 1 month
Trial: 31291923
Drug: Mentalization-Based Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mentalization-Based Treatment (MBT)
Trial: 26888146
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (30 mg/day)
Trial: 26888146
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (60 mg/day)
Trial: 26888146
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human (rh)IGF‐I/rhIGF binding protein‐3 (IGFBP‐3) complex (30 mg/day or 60 mg/day)
Trial: 24081940
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein powder and placebo pill
Trial: 24081940
Drug: Venlafaxine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine and placebo pill
Trial: 21725874
Drug: 2% KZC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% KZC and 2% TET cream (KCZ + TET group)
Trial: 21725874
Drug: 2% KZC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% KZC cream (KCZ group)
Trial: 21725874
Drug: 2% TET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% TET cream (TET group)
Trial: 19370276
Drug: Midazolam 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.075 mg/kg and Dexamethasone 10 mg (MD group)
Trial: 19370276
Drug: Midazolam 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.075 mg/kg (M group)
Trial: 19370276
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg (D group)
Trial: 19370276
Drug: Intravenous normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous normal saline (S group)
Trial: 3665957
Drug: High-dose anticoagulants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose anticoagulants
Trial: 3665957
Drug: Oral warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral warfarin
Trial: 3665957
Drug: Post-warfarin discontinuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-warfarin discontinuation
Trial: 20969563
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment and cream
Trial: 16950289
Drug: Asthma medication
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma medication in adults
Trial: 3898836
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with melphalan and prednisone
Trial: 8845572
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with melphalan
Trial: 8845572
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment with interferon alpha
Trial: 8845572
Drug: Second-line treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line treatment for MM patients who are primary refractory to melphalan
Trial: 8845572
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with melphalan and prednisone
Trial: 2079452
Drug: cefadroxil 1
RxNorm normalized name: CEFADROXIL 1GM TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefadroxil 1 g tid (13 subjects)
Trial: 2079452
Drug: co‐trimoxazole 160/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co‐trimoxazole 160/800 mg bd (23 subjects)
Trial: 2079452
Drug: norfloxacin 400
RxNorm normalized name: norfloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: norfloxacin 400 mg bd (35 subjects)
Trial: 2079452
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (all agents)
Trial: 31500670
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 1.8 g/day for 16 weeks
Trial: 28195952
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (n = 58)
Trial: 28195952
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy and Usual care combined
Trial: 16817913
Drug: peginterferon alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peginterferon alpha‐2b and lamivudine combination
Trial: 20943454
Drug: lamivudine monotherapy
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: lamivudine monotherapy
Trial: 8217354
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (CMF: cyclophosphamide, methotrexate, and 5-fluorouracil)
Trial: 8217354
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant therapy (control)
Trial: 8217354
Drug: Endocrine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine treatment after relapse
Trial: 9865735
Drug: Chemotherapy after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy after relapse
Trial: 8217354
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (CMF) and No adjuvant therapy (control)
Trial: 30160521
Drug: Top quintile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Top quintile (>185 mg/dl)
Trial: 24941843
Drug: Dangfei Liganning
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dangfei Liganning Tablet (DLT), two tablets each time, three times per day for 4 weeks
Trial: 24941843
Drug: Liver‐protecting Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liver‐protecting Tablet (LT), four tablets each time, three times per day for 4 weeks
Trial: 22502713
Drug: Psychosocial factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial factors (e.g., agreeableness, extraversion, stress, social support, self-efficacy)
Trial: 18482155
Drug: Naltrexone monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone monotherapy (50 mg naltrexone + sertraline placebo)
Trial: 18482155
Drug: Naltrexone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone + sertraline (100 mg) plus nine sessions of medical management and supportive advice
Trial: 12886816
Drug: Multimicronutrient supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimicronutrient supplementation (vitamin A, 1000 micrograms; vitamin B1, 1.4 mg; vitamin B2, 1.6 mg; vitamin B6, 1.7 mg; vitamin B12, 2.0 micrograms; folate, 150 micrograms; niacin, 16 mg; vitamin C, 50 mg; vitamin D, 5 micrograms; vitamin E, 8 mg; iron, 18 mg; zinc, 20 mg; copper, 2.0 mg; iodine, 150 micrograms; selenium, 40 micrograms)
Trial: 8890674
Drug: Adjunctive medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive medication (lithium, perphenazine, or paroxetine)
Trial: 8890674
Drug: No adjunctive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjunctive medication
Trial: 4084667
Drug: Prednisolone hemisuccinate
RxNorm normalized name: prednisolone hemisuccinate
DrugBank: Prednisolone hemisuccinate (DB14633)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone hemisuccinate 1200 mg
Trial: 4084667
Drug: Prednisolone hemisuccinate
RxNorm normalized name: prednisolone hemisuccinate
DrugBank: Prednisolone hemisuccinate (DB14633)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone hemisuccinate 75 mg
Trial: 4084667
Drug: Prednisolone hemisuccinate
RxNorm normalized name: prednisolone hemisuccinate
DrugBank: Prednisolone hemisuccinate (DB14633)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone hemisuccinate (both doses)
Trial: 30085292
Drug: Intranasal Oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal Oxytocin (40 IU)
Trial: 29661241
Drug: Cognitive Remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Remediation Therapy (CRT-O)
Trial: 27712772
Drug: Average sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Average sodium intake categories (<2,300, 2,300 to <3,600, 3,600 to <4,800, and ≥4,800 mg/24 h)
Trial: 24999963
Drug: Elevated SDMA
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated SDMA (4th quartile, >1.38 μmol/L)
Trial: 23356027
Drug: 1 year
RxNorm normalized name: COVID vacc 2024-2025 (5-11 years) (Pfizer)/PF 10 mcg/0.3 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 year of WHO‐MDT plus an initial 1 month of daily ofloxacin
Trial: 23356027
Drug: 1 month
RxNorm normalized name: LUPRON-PED 15MG (1 MONTH) SA INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 month of daily rifampicin and daily ofloxacin
Trial: 18564278
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment alone (Control)
Trial: 16403993
Drug: Lamotrigine (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (50-100 mg daily)
Trial: 10937983
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose lisinopril (2.5-5.0 mg/day)
Trial: 10937983
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose lisinopril (32.5-35.0 mg/day)
Trial: 8901854
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg)
Trial: 8901854
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg) in participants smoking at least 20 cigarettes daily
Trial: 8901854
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg) in participants smoking 5-19 cigarettes daily
Trial: 8901854
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg) in participants with higher alcohol intake (> or = 11 g of ethanol/day)
Trial: 8901854
Drug: Beta-carotene (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (20 mg) in participants with lower alcohol intake
Trial: 6753891
Drug: Captopril (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25-50 mg three times daily)
Trial: 6753891
Drug: Captopril +
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril + Hydrochlorothiazide (25-50 mg once daily)
Trial: 6753891
Drug: Atenolol +
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol + Hydrochlorothiazide (25-50 mg once daily)
Trial: 31049877
Drug: Active group
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active group (n = 137, 20 g of whey protein, 3 g of leucine, 800 IU VitD)
Trial: 20431381
Drug: Caspofungin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin (70 mg/m loading dose on day 1, then 50 mg/m daily, maximum 70 mg/d)
Trial: 20431381
Drug: L-AmB (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AmB (3 mg/kg daily)
Trial: 12518369
Drug: L-AmB
RxNorm normalized name: All-ambo-5-((4-(2-(5-(1-hydroxyethyl)pyridin-2-yl)ethoxy)phenyl)methyl)-1,3-thiazole-2,4(3H,5H)-dione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AmB
Trial: 12138325
Drug: Gatifloxacin 400
RxNorm normalized name: gatifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 400 mg under fasting conditions
Trial: 12138325
Drug: Gatifloxacin 400
RxNorm normalized name: gatifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 400 mg under fed conditions
Trial: 7543083
Drug: 50 mmol
RxNorm normalized name: dibasic potassium phosphate 150 MMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mmol magnesium sulfate infusion over 20 hours
Trial: 2475689
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg verapamil HCl sustained‐release tablet (Isoptin SR 240, Securon SR)
Trial: 2475689
Drug: two half
FDA approved: no
EMA approved: no
PMDA approved: no
Description: two half 240‐mg verapamil HCl sustained‐release tablets (2 X half 240‐mg tablets, Study 1)
Trial: 2475689
Drug: two 120-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: two 120-mg verapamil HCl sustained‐release tablets (Isoptin SR 120) (2 X 120 mg, Study 2)
Trial: 31808151
Drug: Sugammadex 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 4 mg.kg-1
Trial: 29277690
Drug: Long-acting β2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting β2 agonists, long-acting muscarinic antagonists (LABAs or LAMAs), LABA/LAMA combination QVA149
Trial: 29277690
Drug: Active treatments
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatments (including LABA/LAMA)
Trial: 25644340
Drug: Whole grain
RxNorm normalized name: Whole grain barley
DrugBank: Barley (DB10506)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole grain (WG) diet (>80 g/d)
Trial: 25644340
Drug: Refined grain
RxNorm normalized name: barley grain
DrugBank: Barley (DB10506)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined grain (RG) diet (<16 g/d)
Trial: 18315425
Drug: Ultrasonic instrumentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonic instrumentation plus application of an 8.8% doxycycline gel
Trial: 18315425
Drug: Adjunctive antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive antibiotic therapy (doxycycline)
Trial: 17195531
Drug: Xenical (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenical (120 mg 3 times a day) with moderate hypocaloric diet
Trial: 6204202
Drug: Positive food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive food challenges (up to 8 g of dehydrated food)
Trial: 29547834
Drug: Tailored FEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored FEC (E 75-90 mg/m2, C 900-1200 mg/m2)
Trial: 29547834
Drug: Standard FEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard FEC (fluorouracil 600 mg/m2, epirubicin 60 mg/m2, cyclophosphamide 600 mg/m2)
Trial: 18833128
Drug: Haloinhalation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloinhalation therapy
Trial: 2317421
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for 90 minutes
Trial: 2317421
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for 120 minutes
Trial: 2317421
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for less than 120 minutes
Trial: 24099414
Drug: Family supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family supportive therapy with generic information